The respiratory system may be involved in all systemic vasculitides, although with a variable frequency. The aim of our review is to describe radiographic and high-resolution CT (HRCT) findings of pulmonary vasculitides and to correlate radiological findings with pathological results. Lung disease is a common feature of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitides, including granulomatosis with polyangiitis (Wegener's), eosinophilic granulomatosis with polyangiitis (Churg-Strauss) and microscopic polyangiitis. Pulmonary involvement is less frequent in immune-complex-mediated small-vessel vasculitides, such as Behçet's disease and Goodpasture's syndrome. Pulmonary involvement associated to large-vessel (gigantocellular arteritis and Takayasu's disease) or medium-vessel (nodose polyarteritis and Kawasaki's disease) vasculitides is extremely rare. The present review describes the main clinical and radiological features of pulmonary vasculitides with major purpose to correlate HRCT findings (solitary or multiple nodules, cavitary lesions, micronodules with centrilobular or peribronchial distribution, airspace consolidations, "crazy paving", tracheobronchial involvement, interstitial disease) with pathological results paying particular attention to the description of acute life-threatening manifestations. A thorough medical history, careful clinical examination and the knowledge of radiological patterns are mandatory for a correct and early diagnosis.
INTRODUCTION
The systemic vasculitides are a heterogeneous group of disorders characterized by an inflammatory destructive process affecting blood vessels. 1 The lung is frequently involved with various clinical presentations. Pulmonary vasculitides may be primary and, in most cases, idiopathic disorder or secondary to other conditions such as infectious diseases, connective tissue diseases, malignancies and hypersensitivity disorders. 2 Primary pulmonary vasculitides are rare disorders, with an incidence of 20-100 cases per million and a prevalence of 150-450 per million. [2] [3] [4] [5] The most widely used approach to classifying primary vasculitides is based on the size of the affected vessels (large, medium, small). Primary vasculitides most commonly associated with thoracic involvement are small-vessel antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides represented by granulomatosis with polyangiitis (Wegener's) (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) and microscopic polyangiitis.
Pulmonary involvement is less frequently associated to small-vessel immune-complex-mediated vasculitides as Goodpasture's syndrome and Behçet's disease.
Pulmonary involvement related to large-vessel vasculitides (Takayasu arteritis, giant-cell arteritis) and medium-sized-vessel vasculitides (polyarteritis nodosa and Kawasaki disease) is rare. 2 Radiological manifestations of primary pulmonary vasculitides are extremely variable and can be characterized by several findings including small-vessel wall thickening, nodular lesions, cavitary lesions, micronodules with centrilobular and peribronchial distribution, "ground-glass" opacities and/or consolidations, "crazy-paving" pattern, tracheobronchial stenoses and aneurysmatic dilatation of pulmonary arteries.
The knowledge of these signs and a careful correlation of specific clinical, laboratory, radiological and pathological features are mandatory for early diagnosis of vasculitides also in biopsyproven cases.
Chest radiography is often non-specific and does not show the right pattern and extent of thoracic involvement. Highresolution CT (HRCT) is the most effective method to evaluate the characteristics, distribution and evolution of lung disorders.
As mentioned above, the primitive pulmonary vasculitides are rare disorders and represent one of the most complex diagnosis in medicine characterized by non-specific symptoms and signs common to other diseases such as infectious, connective tissue and neoplastic disease; in addition, the diagnosis of vasculitis is based on the identification of specific patterns of clinical, radiological, laboratory and histopathological abnormalities. The association of serological testing for ANCA with other immunopathological markers such as immunoglobulin A, serum cryoglobulins and anti-glomerular basement membrane is equally important for the diagnosis.
CLASSIFICATION OF THE VASCULITIDES
The size of the predominantly involved vessels strongly influences the clinical and radiological features of the different forms of vasculitides and is therefore one major criterion for the classification of vasculitides. Primary vasculitides are classified into large-vessel vasculitides, medium-sized-vessel vasculitides and small-vessel vasculitides. Large-vessel vasculitides affect the aorta and its largest branches; the medium-sized-vessel vasculitides affect the main visceral arteries and their branches; and the small-vessel vasculitides affect the capillaries, venules and arterioles. Note how all three categories affect arteries, but only small-vessel vasculitis affects also capillaries and venules. The 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides elaborated a new classification system 6 (Table 1) .
In this review, we describe the radiological, pathological and clinical features of primary vasculitides that most frequently involve the lung, represented by primary small-vessel ANCAassociated vasculitides [EGPA (Churg-Strauss), granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis] and primary immune-complex-mediated vasculitides (Behcet's disease and Goodpasture's syndrome).
We also discuss the radiological findings and the underlying causes of diffuse alveolar haemorrhage (DAH) which is The diagnosis of small-vessel vasculitides needs pathological manifestations of vasculitic involvement of capillaries and venules, such as glomerulonephritis, purpura or pulmonary capillaritis. Primary, idiopathic, ANCAassociated small-vessel vasculitides are characterized by a more frequent lung involvement; ANCAs are antibodies directed against the intracellular antigens of neutrophils and monocytes. The most common primary systemic small-vessel vasculitides in adults are ANCA-associated small-vessel vasculitides which include three major categories: EGPA (Churg-Strauss), granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.
EGPA (Churg-Strauss) and granulomatosis with polyangiitis (Wegener's) appear with as necrotizing granulomatous inflammation, whereas microscopic polyangiitis appears with as necrotizing inflammation without granulomatosis. 6 These three nosological entities are joined by particular clinical features, histopathological involvement of small vessels, similar response to immunosuppressive treatment and positivity for ANCA. ANCA positivity is common but not always present in these vasculitides, thus ANCA negativity does not completely rule out these vasculitides (negative-predictive value of 90%). 6 In addition to these three diseases, there are other two forms of small-vessel vasculitides not associated with ANCA, but related to immune complexes deposition, such as Behçet's disease and Goodpasture's syndrome-the latter characterized by the presence of antibodies that selectively target antigens of the glomerular and alveolar basement membrane; it is a cause of pulmonary-renal syndrome.
Small-vessel vasculitides can affect people of all ages but are most common in adults 50-69 years of age, and they affect males slightly more frequently than they affect females. 6 
GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S)
The aetiopathogenesis of granulomatosis with polyangiitis is unknown and probably multifactorial; ANCAs certainly have a key role in vascular inflammation pathogenesis.
The prevalence is about 1.5-3 cases per 100,000 inhabitants; adults between 30 and 50 years of age are mainly affected, without sex predilection. The advanced age of onset and the early renal involvement are negative prognostic factors.
The clinical disease's onset is generally acute and characterized by dyspnoea, cough and haemoptysis due to lower respiratory tract involvement. The upper airway involvement is frequent (50-70% of patients); the kidneys are involved in 75-85% of patients; the nervous system is involved in 20-35%; the eye is involved in 10-15%; the skin is involved in 10-15%, and the muscles and joints are involved in 30%. 2, 7 The typical histopathological lesions of granulomatosis with polyangiitis are necrosis, vasculitides (which generally affects arterioles, venules and capillaries and is usually focal and eccentric to the lumen) and granulomatous inflammation (inflammatory infiltrate is composed by neutrophils, lymphocytes, plasma cells, macrophages, eosinophils and giant cells). The presence of a rim of ground-glass opacity in the pulmonary parenchyma surrounding lung nodules is frequent and is expression of alveolar haemorrhage that sometimes can spread and represent the predominant HRCT abnormality.
An association with immunological diseases such as calcinosis, Raynaud phenomenon, oesophageal dysmotility, sclerodactyly and telangiectasia (CREST) syndrome and Hashimoto's thyroiditis is described.
Radiological findings
The most common HRCT abnormalities are lung nodules, usually multiple and bilateral which tend to increase with disease progression. It can range from few millimeters to .10 cm in diameter and become cavitated. Cavities are usually thick walled and characterized by an irregular inner margin ( Figure 1 ) and absent calcification. The nodular lesions are often related to the vessels, and they tend to involve mainly the subpleural regions but have no predilection for the upper or lower lung zones. The presence of a rim of ground-glass opacity around the nodules (halo sign) is frequent and is the expression of alveolar haemorrhage ( Figure 2) ; the presence of an air bronchogram within pulmonary nodules is equally typical (Figure 3 ). After therapy, the lesions usually show a slow resolution characterized by a marked wall thinning ( Figure 4 ). In cases of DAH, HRCT features consist of bilateral ground-glass opacities and consolidations usually prominent in the perihilar areas with a relative sparing of the subpleural pulmonary parenchyma ( Figure 5 ), pulmonary apices and costophrenic angles. The crazy paving pattern characterized by a smooth and regular interlobular septal thickening associated with ground-glass opacity may be seen some days later in an acute episode of haemorrhage ( Figure 6 ).
Diagnosis
In presence of an appropriate clinical context and compatible radiological findings, the ANCA positivity should be considered highly suggestive of Wegener. The evidence of necrotizing granulomatous vasculitides in the affected sites (lung, kidney, skin etc.) allows the histological confirmation of the disease. Surgical open-lung biopsy is the gold standard technique for the definitive diagnosis while transbronchial biopsy often does not provide diagnostic material.
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS)
Also known as allergic granulomatous angiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss) is characterized by a clinical triad: asthma, hypereosinophilia and necrotizing systemic vasculitis. 8 The diagnosis is based on the presence of four or more of the following six findings: asthma, .10% eosinophilia in a differential white blood cell count, mononeuropathy or polyneuropathy due to a systemic vasculitis, paranasal sinus abnormalities, migratory or transient pulmonary opacities and histological evidence of extravascular eosinophils in a biopsy specimen. 9 Late age of onset (mean age of 32 years) of asthma allows us to distinguish EGPA (Churg-Strauss) asthma from typical asthma in the general population. 10 The lung is the most commonly involved organ, followed by the skin. DAH (haemorrhagic alveolitis) and glomerulonephritis are more or less common than in the other forms of vasculitides.
The heart is an important target organ in EGPA (ChurgStrauss), and the main causes of morbidity and mortality are represented by coronary arteritis. 11 Histological findings include granulomatous necrotizing vasculitis of the small arteries and eosinophil-rich inflammatory infiltrate. 12 Clinically, EGPA (Churg-Strauss) shows three distinct phases: (a) the prodromal period, which may persist for several years, consisting of asthma and allergic rhinitis; (b) a phase of marked peripheral blood eosinophilia and eosinophil tissue infiltrates; (c) and a life-threatening vasculitic phase. 13 The first two prevasculitic phases are characterized by marked tissue eosinophilia, which manifests in the lung as eosinophilic pneumonia. 14 
Radiological findings
The most frequently observed radiological sign in patients with EGPA (Churg-Strauss) consists of transient and often migrant opacities with bilateral and non-segmental distribution, mostly peripheral, without predilection for any craniocaudal lung zone.
14 This aspect is similar to eosinophilic pneumonia and organizing pneumonia. 15, 16 The most common abnormality at HRCT, seen in up to 90% of patients, is bilateral areas of ground-glass opacity or consolidation with a bilateral symmetric distribution and a peripheral predominance. Other relatively common findings are the presence of airway involvement consisting of bronchial dilatation, bronchial wall thickening and small peribronchial and centrilobular nodules (Figures 7 and 8 ) related to eosinophilic infiltration of the bronchial wall and asthma.
14 Regular and smooth interlobular septal thickening, which may reflect the presence of oedema secondary to cardiac involvement or eosinophilic septal infiltration, can be seen in 50% of patients ( Figure 9 ).
Diagnosis
In asthmatic patient, the presence of bilateral parenchymal areas of consolidation with prevalent peripheral distribution can suggest a diagnosis of chronic eosinophilic pneumonia, EGPA (Churg-Strauss) or organizing pneumonia. The presence of blood eosinophilia is typical of the first two diseases but is not frequent in organizing pneumonia. The presence of systemic manifestations related to EGPA (Churg-Strauss), including rash, peripheral neuropathy, sinusopathy and the presence of perinuclear ANCA in serum, allow to make the diagnosis even without biopsy. In case of ANCA negativity (30-40%), the biopsy confirmation is recommended. Biopsy confirmation is recommended when easily accessible lesional tissue, e.g. skin, is available.
MICROSCOPIC POLYANGIITIS
Microscopic polyangiitis is a non-granulomatous necrotizing systemic vasculitis with the involvement of small vessels. It is the most common cause of pulmonary-renal syndrome, a syndrome characterized by the coexistence of alveolar haemorrhage, due to alveolar capillaritis, and necrotizing glomerulonephritis. 17 More than 80% of patients have a rapidly progressive glomerulonephritis at presentation, associated to diffuse pulmonary haemorrhage in 30-50% of the cases. 7, 18, 19 Thoracic symptoms include dyspnoea, haemoptysis and progressive anaemia; other common manifestations include skin lesions, peripheral neuritis and ocular symptoms such as other smallvessel vasculitides.
It is considered to be the small-vessel variant of polyarteritis nodosa which affects only medium-sized muscular arteries and does not involve the lungs.
Over the differences in the involved vessels' size, other differences from polyarteritis include the following: lung involvement is unusual in polyarteritis nodosa; microscopic polyangiitis is almost never associated with a previous hepatitis B virus and hepatitis C virus infections; the rapidly progressive glomerulonephritis does not occur in polyarteritis nodosa.
Radiological findings
The radiological lung features consist of diffuse bilateral airspace opacities related to DAH or haemorrhagic diffuse alveolitis.
The HRCT pattern is characterized by ground-glass opacities more or less associated with areas of consolidation (related to the presence of completely blood-filled alveoli) usually bilateral, diffused or patchy (Figure 10 ).
The clinical evolution of haemorrhagic alveolitis is often dramatic and can be fatal if not promptly treated.
In favourable cases, the parenchymal opacities usually resolve within 1-2 weeks, slower than acute pulmonary oedema that is the most important radiological differential diagnosis. The differential diagnosis with diffuse alveolar involvement secondary to infective diseases is more difficult; in these cases, clinical signs are mandatory for diagnosis.
After the acute phase, a reticular pattern could be present. It can persist when recurrent haemorrhage occurs and may progress to pulmonary fibrosis.
Diagnosis
The diagnosis of microscopic polyangiitis should be suspected in patients with clinical and radiological findings of diffuse pulmonary haemorrhage and ANCA-positive rapidly progressive glomerulonephritis. Clinically, the main differential diagnosis is with Goodpasture's syndrome, granulomatosis with polyangiitis and systemic lupus erythematosus characterized by pulmonary and renal manifestations. In these cases, serum tests are fundamental for the correct diagnosis characterized by the presence of antiglomerular basement membrane antibodies; renal biopsy is generally performed to differentiate microscopic polyangiitis (non-granulomatous necrotizing systemic vasculitis) from granulomatosis with polyangiitis (granulomatous necrotizing vasculitis) and systemic lupus erythematosus (immune complex deposition vasculitis). 20 DIFFUSE ALVEOLAR HAEMORRHAGE DAH can be defined by the presence of haemoptysis, diffuse alveolar infiltrate and a drop in haematocrit. It is a clinical syndrome usually related to all primary or secondary small-vessel vasculitides with capillaritis as granulomatosis with polyangiitis (Wegener's), EGPA (Churg-Strauss), microscopic polyangiitis, Henoch-Schönlein purpura, Behçet's disease, connettivitis (especially systemic lupus erythematosus), antiphospholipid antibody syndrome and Goodpasture's syndrome. 2, 18, 21 These conditions must be differentiated from other diseases responsible of diffuse pulmonary haemorrhage such as drug-inducted pulmonary damage or inhalation of toxic substances.
The radiological findings are common among all these forms, and it is already described in microscopic polyangiitis. BEHÇET'S DISEASE Behçet' s disease is a rare chronic multisystemic vasculitis that usually appears during the second and third decades of life and is characterized by ocular anomalies (uveitis), ulcers affecting the mouth and genitals and additional clinical manifestations in multiple organ systems. Pulmonary involvement is present in 10% of cases. The vasculitis can involve large, medium and small vessels of both the arterial and venous circulation. 22 Large-vessel involvement is characterized by arterial or venous occlusion and the presence of aneurysms. The pulmonary arteries are the second most common site of arterial involvement, preceded by the aorta. Behçet's disease is the most common cause of pulmonary artery aneurysms (Figure 11 ) caused by inflammation of the vasa vasorum of the tunica media with destruction of the elastic fibres and dilatation of the vessel lumen. 23, 24 Haemoptysis is the most common presenting symptom and is one of the leading causes of death. 23 Pulmonary aneurysms in Behçet's disease are fusiform to saccular, generally multiple and bilateral, frequently partially or totally thrombosed. The aneurysms frequently involve main or lower lobe pulmonary arteries. 24, 25 Thrombosis of the superior vena cava and of other mediastinal veins is often present (Figure 11 ). In untreated patients, mortality rate is higher, whereas they are much lower in patients receiving immunosuppressant treatment. 18, 25 The most common parenchymal lesions are ill-defined areas of increased opacity, which represent focal vasculitis and thrombosis of pulmonary vessels resulting in infarction, haemorrhage and focal atelectasis. 23, 25 GOODPASTURE'S SYNDROME Goodpasture's syndrome is an extremely rare small-vessel vasculitis (one case per million per year) characterized by the presence of antibodies that selectively targets antigens of the glomerular and alveolar basement membrane; it is a cause of pulmonary-renal syndrome. The radiographic and CT lung features are consistent with DAH ( Figure 12 ).
CONCLUSION
The diagnosis of vasculitis is often delayed because several other diseases have similar clinical manifestations. 
